CEP-32496
CEP-32496 Basic information
- Product Name:
- CEP-32496
- Synonyms:
-
- CEP-32496
- 1-(3-(6,7-diMethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-Methylpropan-2-yl)isoxazol-3-yl)urea hydrochloride
- CEP 32496 hydrochloride
- CEP-32496 (hydrochloride)
- CEP32496 hydrochloride
- CEP-32496 HCl salt
- 1-(3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxaz
- N-[3-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenyl]-N'-[5-(2,2,2-trifluoro-1,1-dimethylethyl)-3-isoxazolyl]urea hydrochloride
- CAS:
- 1227678-26-3
- MF:
- C24H23ClF3N5O5
- MW:
- 553.9181296
- Mol File:
- 1227678-26-3.mol
CEP-32496 Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- Soluble in DMSO
- form
- Powder
CEP-32496 Usage And Synthesis
Uses
CEP 32496 is an orally active BRAFV600E inhibitor with selective cellular and in vivo antitumor activity.
in vivo
Oral administration of Agerafenib (CEP-32496) to Colo-205 tumor xenograft-bearing mice results in significant inhibition of pMEK in tumor cell lysates. For instance, a single 30 mg/kg (po) dose of Agerafenib (CEP-32496) leads to a 50 and 75% inhibition of normalized pMEK in tumor lysates at the 2 and 6 h postdose time point, respectively (p<0.03), while a 55 mg/kg (po) dose resulted in a 75% to 57% (p<0.03) inhibition of pMEK at 2 through 10 h post administration, with normalization to baseline by 24 h. Agerafenib (CEP-32496) exhibits an exceptional PK profile in mouse, dog, and cynomolgus monkey. Administration of Agerafenib (CEP-32496) to beagle dogs (single dose of 1 mg/kg iv and 10 mg/kg po) results in low clearance (CL=5.0 (mL/min)/kg) and excellent bioavailability (%F=100). Similarly, in cynomolgus monkey, the administration of Agerafenib (CEP-32496) (single dose of 1 mg/kg iv and 10 mg/kg po) leads to high oral exposure due to low clearance (CL=6.7 mL/min/kg) and excellent bioavailability (%F=100)[1].
target
wild-type BRAF
IC 50
BRafV600E: 14 nM (Kd); Braf: 36 nM (Kd); CRAF: 39 nM (Kd); c-Kit: 2 nM (Kd); Ret: 2 nM (Kd); LCK: 2 nM (Kd); Abl-1: 3 nM (Kd); VEGFR-2: 8 nM (Kd); CSF-1R: 9 nM (Kd); EPHA2: 14 nM (Kd); EGFR: 22 nM (Kd); c-Met: 513 nM (Kd); JAK-2: 4700 nM (Kd); MEK-1: 7100 nM (Kd); MEK-2: 8300 nM (Kd)
CEP-32496Supplier
- Tel
- 0086-21-58956006
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- 021-58955995
- sales@medchemexpress.cn
- Tel
- +1 (866) 930-6790
- info@adooq.com
- Tel
- Mobile:13665161512
CEP-32496(1227678-26-3)Related Product Information
- Testolactone
- GDC-0077
- AGI6780
- CC0651
- 6-Amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine
- IDO-IN-7
- UNC 0631
- XL 228
- N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea
- Ethyl 5-oxo-1-phenyl-2-pyrazoline-3-carboxylate
- 5-(1,1,1-Trifluoro-2-methylpropan-2-yl)isoxazol-3-amine
- Sorafenib
- Pazopanib
- Encorafenib (LGX818)
- Dabrafenib
- Regorafenib
- Plx-4032 (RG7024)
- PLX4032